ACR DSI shares list of FDA-cleared AI algorithms for medical imaging

The American College of Radiology (ACR) Data Science Institute (DSI) has created a new resource for radiology researchers: a full list of FDA-cleared AI algorithms related to medical imaging.  

The list includes a wide range of AI models and was designed to save researchers valuable time. The list includes a summary of each algorithm’s manufacturer, intended purpose, FDA product area and more.

“Models range from detecting pneumothorax in chest X-rays to highlighting segments of the brain on MRI,” according to a statement from the ACR. “Several models may increase efficiency by detecting positive findings on images and notifying the radiologist of the suspected findings for further action.”

The full list, published on the ACR DSI website, will be updated regularly.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.